Table 6.
Association between response to RAI therapy and BRAFV600E status in PTC patients with high recurrence risk.
Response to therapy | BRAFV600E mutant group | BRAFV600E wild-type group | P value |
---|---|---|---|
Excellent response | 148 (47.7%) | 32 (48.5%) | 0.498 |
Indeterminate response | 42 (13.5%) | 5 (7.6%) | |
Biochemical incomplete response | 19 (6.1%) | 3 (4.5%) | |
Structural incomplete response | 101 (32.6%) | 26 (39.4%) |